Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

Global markets lost momentum over the ever-rising number of COVID-19 infections - Tuesday Review, October 27

Global markets lost momentum over the ever-rising number of COVID-19 infections - Tuesday Review, October 27

The markets extended loses as the virus continued to wreak havoc

The US

The markets switched their focus from the stimulus package to the rising number of COVID-19 infections. As of yesterday, the States have reported more than 8.7 million infections. USA30 lost 0.80%, while USA500 closed 0.30% lower. TECH100 went up 0.64%.

Brent Oil gained 0.87% at $40.81 per barrel. Crude was up 0.78% at $38.86.

Gold added 0.32% to $1,907.64 an ounce.

Asia and Australia

The benchmarks fell as investors were fearful of the ever-rising number of COVID-19 infections. Japan225 dropped 0.11%.

HongKong45 slid 0.76%.

Down under, Australia200 closed down 1.7%, marking its worst session in a month.

USD/JPY lost 0.03% to 104.78.

Europe

Europe50 and Germany30 each fell 0.9%. France40 slipped 1.6%, reaching a one-month low.

The drops came as the markets are worried about a new economic fallout. In Germany, Chancellor Angela Merkel announced a potential “lockdown light” of bars and restaurants.

Sources: marketwatch.com, reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com